Autolus Therapeutics plc (AUTL) Financials

AUTL Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 375.4 million 263.9 million
2023-09-30 406.1 million 225.6 million
2023-06-30 451.0 million 221.7 million
2023-03-31 460.0 million 193.1 million

AUTL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -26.3 million 3.3 million
2023-09-30 -41.7 million 2.9 million
2023-06-30 -42.5 million 2.7 million
2023-03-31 -46.0 million 2.4 million

AUTL Net Income

No data available :(

AUTL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 53.0 million
2023-09-30 256.4 million - 52.5 million
2023-06-30 307.5 million - 50.9 million
2023-03-31 343.0 million - 27.3 million

AUTL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 174.1 million
2023-09-30 174.0 million
2023-06-30 173.9 million
2023-03-31 173.8 million

AUTL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.5 million 25.2 million 15.7 million -
2023-09-30 1.5 million 37.2 million 10.6 million -
2023-06-30 4.4 million 36.7 million 11.1 million -
2023-03-31 3.6 million 31.3 million 9.3 million -

AUTL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 406000 382000
2023-06-30 - 1.5 million
2023-03-31 1.3 million 1.9 million

AUTL

Price: $4.08

52 week price:
1.61
7.45

Earnings Per Share: -1.20 USD

P/E Ratio: -6.15

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 412700

Market Capitalization: 1.3 billion

Links: